Document:

Form of Employment Agreement of senior executive officers

 Exhibit 10.2 
  

			
	Simcere Pharmaceutical Group	  	Employment Agreement

 FORM OF EMPLOYMENT AGREEMENT 
 This Employment Agreement (this “Agreement”) is entered into on this
            , 200  , by and between Simcere Pharmaceutical Group (the “Company”), and [Name of employee], (the “Employee”).

 WHEREAS, the Company has appointed the Employee to the position of [position/title], and the Employee has accepted such
appointment; 
 WHEREAS, in connection with such appointment, the Company and the Employee desire to enter into this Agreement; 

NOW, THEREFORE, in consideration of the Employee’s appointment as [position/title], and for other good and valuable consideration the
receipt of which is hereby acknowledged, it is agreed by the Employee and Company as follows: 
 Section 1. Employment

 The Company hereby employs the Employee as [position/title]. The term of the employment, pursuant to this Agreement, will
commence on             , (the “Commencement Date”) and will continue until
                    (“Employment Term”), or the termination of this Agreement as described in Section 9 hereof, whichever shall
occur first. The Employee hereby accepts such employment. 
 Section 2. Job Responsibilities 
 The Employee shall perform such responsibilities during the Employment Term as follows: 
  

	 	(a)	Provision of advice to the company relating to technology choice and improvements 

  

	 	(b)	Assist with improving the company production technology to improve device performance and/or reduce cost. 

  

	 	(c)	Analyze devices and/or modules as required to identify causes of problems with production and assist with finding solutions to such problems. 

  

	 	(d)	Provide training for staff in appropriate areas. 

  

	 	(e)	Assist with assessment procedures for technician and production staff in relevant areas. 

  

	 	(f)	Any other responsibilities as assigned by Dr. Shi. 

 Section 3. Remuneration 
 Subject to the terms and conditions of this Agreement, during the Employment Term, the
remuneration package is as follows: 
  

	 	(a)	The working hour of the Employee shall be [  ]% of working hour per year, comprising [  ]% in attendance at the premises of the company and the other
[  ]% working on company projects in other locations, primarily at [  ]. 

	 	

			
	Simcere Pharmaceutical Group	  	Employment Agreement

  

	 	(b)	The Employee shall receive a monthly salary of USD[  ] payable before the 10th of each month. The salary shall be paid directly into the banking account of the Employee.

  

	 	(c)	The Employee shall pay his own tax in compliance with the relevant laws and regulations of China. 

  

	 	(d)	The Employee shall submit the working visa and other relevant applications to the local authority. The Company shall provide the necessary employment documents for the above
mentioned applications. 

 Section 4. Fringe Benefits 
 The Employee shall be entitled to participate in the following benefit plans and programs: 
  

	 	(a)	Transportation Benefits. 

  

	 	(1)	The Company shall provide round trip tickets (business class) between Shanghai and [location] for the Employee. 

  

	 	(b)	Stock options. 

 Subject to approval by the Compensation
Committee, the Company will grant to the Employee, pursuant to the Company’s 2006 Share Incentive Plan (the “Plan”), an option to purchase
                 Ordinary Shares of the Company at an exercise price of US$4.20. The Option shall vest pursuant to the terms of the stock option agreement between
the Company and the Employee, (the “Option Agreement”), which shall specify that one-fifth of option to purchase an aggregate of              Ordinary Shares shall vest on
each of November 15, 2007, 2008, 2009, 2010, 2011, respectively. 
 Section 5. Reimbursement for Expenses during Business Trips

 The Company shall reimburse the Employee, in accordance with the Company’s policies and practices in effect from time to time, for
all the Expenses hereunder reasonably incurred by the Employee in performance of the Employee’s duties during business trips. 
  

	 	(a)	Expenses shall include the transportation cost, accommodation fee, catering fee in business trip and shall be reimbursed upon the submission of receipts. 

 

	 	(b)	Other expenses including the laundry fee, paid television fee and other private expenses shall be responsible by the Employee. 

  

	 	(c)	Business trips aforesaid shall be approved by the Company. 

  

 2 

			
	Simcere Pharmaceutical Group	  	Employment Agreement

  

 Section 6. Employee Inventions 
  

	 	(a)	The term “Employee Inventions” means any and all processes, inventions, technology, computer programs, original works of authorship, designs, formulas, patents,
discoveries, copyrights and all improvements, rights, and claims that are conceived, developed or reduced to practice by the Employee alone or with others. 

  

	 	(b)	Any and all Employee Inventions which the Employee has conceived or made, or may conceive or make during the Employment Term using the Company’s equipment, supplies, facilities
or trade secret, directly or indirectly, connected with the Company’s business, shall be the sole and exclusive property of the Company. The Employee agrees that all patentable and copyrightable works created by the Employee while working on
company projects or under the Company’s direction, in connection with the Company’s business are “works made for hire” and the Employee hereby assigns all proprietary rights, including patent and copyright, in these works to the
Company without further compensation. 

  

	 	(c)	The Employee further agrees to (i) disclose promptly to the Company all such Employee Inventions which the Employee has made or may make while working on company projects
solely, jointly or commonly with others, (ii) assign all such Employee Inventions to the Company, and (iii) execute and sign any and all applications, assignments or other instruments which the Company may deem necessary in order to enable
it, at its expense, to apply for, prosecute, and obtain patents, copyrights, or other proprietary rights in China and foreign countries, or in order to transfer to the Company all right, title and interest in said Employee Inventions.

  

	 	(d)	Any Employee Inventions which the Employee can demonstrate to be developed entirely on the Employee’s own time without using the Company’s equipment, supplies, facilities
or trade secret shall belong to the Employee. The Employee shall disclose promptly to the Company all such Employee Inventions. 

  

	 	(e)	Inventions made by the Employee prior to his employment shall be notified to the Company. Eventual rights for utilisation of results from copyright work performed by the Employee
shall exclusively belong to the Company. Any employee inventions developed through R&D projects at [institution/location] not funded by the company, shall be the property of [institution/location] or the appropriate funding organisation. For
example, inventions arising from collaborative research between [institution/location] and [institution/location] relating to the use of inkjet printing in solar cell fabrication, and funded by these organisations, shall be the property of these
organisations. 

  

	 	(f)	Other provisions refer to Exhibit A hereunder. 

  

 3 

			
	Simcere Pharmaceutical Group	  	Employment Agreement

  

 Section 7. Confidential Information. 
  

	 	(a)	The Employee recognizes and acknowledges that he will have access to certain information of the Company and that such information is confidential and constitutes valuable, special
and unique property of the Company. The parties agree that the Company has a legitimate interest in protecting the Confidential Information, which includes all the commercial and technological secrets and know-how and other confidential information
of the Company. The parties agree that the Company is entitled to protection of its interests in the Confidential Information. The Employee shall not at any time, either during or subsequent to the term of this Agreement, disclose to others, use,
copy or permit to be copied, except in pursuance of his duties for an on behalf of the Company, it successors, assigns or nominees, any Confidential Information of the Company (regardless of whether developed by the Employee) without the prior
written consent of the Company. 

  

	 	(b)	The parties agrees that in the event of a violation of this covenant against non-use and non-disclosure of Confidential Information, that the Company shall be entitled to a recovery
of damages from Employee and/or an injunction against the Employee for the breach or violation or continued breach or violation of this covenant or the confidential agreement mentioned above. 

  

	 	(c)	The Employee shall not issue any publications and papers containing any Confidential Information of the Company without the prior written consent of the Company.

  

	 	(d)	The Employee agrees to sign a Confidential Agreement in Exhibit A hereunder with the Company. 

 Section 8. Non-competition 
  

	 	(a)	During the Employment Term, the Employee shall devote his full business efforts (see 3(a)) and time to the Company. Employee agrees, during the Employment Term for a period of 6
months thereafter, not to actively engage in any other employment, occupation, consulting activity or business referral for any direct or indirect remuneration without the prior approval of the Company; provided, however, that Employee may serve in
any capacity with any civic, educational or charitable organization, or as a member of corporate Boards of Directors or committees thereof, without the approval of the Company, unless there is a conflict of interest. 

  

	 	(b)	During the Employment Term, the Employee shall declare any shareholdings and interest in other companies in which there is a conflict interest with the Company. (The employee holds
[  ] shares in [institution/location], purchased for [  ]$ each in [  ].) 

  

	 	(c)	Other provisions refer to Exhibit A hereunder. 

  

 4 

			
	Simcere Pharmaceutical Group	  	Employment Agreement

  

 Section 9. Termination of Employment. 
  

	 	(a)	Death of Disability. The Employee’s employment shall terminate automatically upon the Employee’s death. The Company shall be entitled to terminate the Employee’s
employment because of the Employee’s Disability during the Employment Period. “Disability” means that the Employee has been unable for 30 consecutive business days, to perform the Employee’s duties under this Agreement, as a
result of physical or mental illness or injury. A termination of the Employee’s employment by the Company for Disability shall be communicated to the Employee by written notice, and shall be effective on the 30th day after receipt of such
notice by the Employee (the “Disability Effective Date”), unless the Employee returns to full-time performance of the Employee’s duties before the Disability Effective Date. The Employee is entitled to the payment of
                    . 

  

	 	(b)	Termination by the Company. (i) The Company may terminate the Employee’s employment for Cause. “Cause” means (A) the conviction of the Employee for the
commission of a felony from which all final appeals have been taken, or (B) willful gross misconduct by the Employee in connection with his employment by the Company, in either case that results in material and demonstrable financial harm to
the Company. The Company shall give the Employee prior written notice      days in advance of its intention to terminate the Employee’s employment for Cause, setting forth in reasonable detail the specific conduct of
the Employee that it considers to constitute Cause and the specific provision(s) of this Agreement on which it relies. The Employee is entitled to the payment of
                    . (ii) The Company may terminate the Employee’s employment without Cause by giving prior written notice
     days in advance and the Employee is entitled to the payment of                     . 

 

	 	(c)	Termination by Employee. (i) The Employee may terminate employment for Good Reason, which means any material breach of this Agreement by the Company that is not remedied by the
Company promptly after receipt the remedy request from the Employee. A termination of employment by the Employee for Good Reason shall be effectuated by giving the Company prior written notice      days in advance of the
termination, setting forth in reasonable detail the specific conduct of the Company that constitutes Good Reason and the specific provision(s) of this Agreement on which the Employee relies. The Employee is entitled to the payment of
                    . (ii) The Employee may terminate employment without Good Reason with prior written notice
     days in advance and the Employee is entitled to the payment of                     . 

Section 10. Concluding provisions 
  

	 	(a)	The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of mainland of the Republic of China. 

  

 5 

			
	Simcere Pharmaceutical Group	  	Employment Agreement

  

	 	(b)	The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provisions of this Agreement, which
shall remain in full force and effect. 

  

	 	(c)	Except as other provided herein, this Agreement sets forth the entire agreement of the parties hereto in respect of the subject matter contained herein and supersede all prior
agreements, promises, covenants, arrangements, communications, representations or warranties, whether oral or written, by any officer, employee or representative of any party hereto in respect of such subject matter. Except as other provided herein,
any prior agreement of the parties hereto in respect of the subject matter contained herein is hereby terminated and cancelled. 

  

	 	(d)	When the two parties dispute over this contract, both parties shall make their best effects to resolve the dispute through friendly consultation and mediation. If such consultation
or mediation fails to resolve the dispute, either party may resort to legal procedure in the local court where the Company located. 

  

	 	(e)	This Agreement shall have two (2) counterparts, each of which shall have the same legal effect. 

 [Remaining Page Intentionally Left Blank] 
  

 6 

			
	Simcere Pharmaceutical Group	  	Employment Agreement

  

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their respective duly
authorized representatives: 
  

			
	Simcere Pharmaceutical Group
		
	 By:
	 	  

		 	(Authorized Signature of the Legal Representative)
		
	 Title:
	 	Chief Executive Officer

  

			
	 Place of Execution:
	 	  

  

			
	 [Name of employee]

		
	 By:
	 	  

		 	(Signature)

  

			
	 Place of Execution:
	 	  

  

 7 

			
	Simcere Pharmaceutical Group	  	Employment Agreement

  

 Exhibit A 
 NON-DISCLOSURE, NON-COMPETITION AND PROPRIETARY 
 INFORMATION AGREEMENT 
 In partial consideration and as a condition of my employment by Simcere Pharmaceutical Group (the “Company”), and effective as of the date that
my employment by Company first commenced, I hereby agree as follows: 
 1. Non-Disclosure 
  

	 	A.	I will hold all Company Confidential Information in confidence and will not disclose, use, copy, publish, summarize, or remove from the premises of Company any Confidential
Information, except (a) as a necessary to carry out my assigned responsibilities as a Company employee, and (b) after termination of my employment, only as specifically authorized in writing by an officer of Company. However, I shall not
be obligated under this paragraph with respect to information I can document is or becomes readily publicly available without restriction through no fault of mine. “Confidential Information” shall mean all information related to any
aspect of the business of Company which is either information not known by actual or potential competitors of Company or is proprietary information of Company, whether of a technical nature or otherwise. Confidential Information includes inventions,
disclosures, processes, systems, methods, formulae, devices, patents, patent applications, trademarks, intellectual properties, instruments, materials, products, patterns, compilations, programs, techniques, sequences, designs, research or
development activities and plans, specifications, computer programs, source codes, costs of production, prices or other financial data, volume of sales, promotional methods, marketing plans, lists of names or classes of customers or personnel, lists
of suppliers, business plans, business opportunities or financial statements. 

  

	 	B.	I will safeguard and keep confidential the proprietary information of customers, vendors, consultants and other parties with which Company does business to the same extent as if it
were Company Confidential Information. I will not, during my employment with Company or otherwise, use or disclose to Company any confidential, trade secret or other proprietary information or material of any previous employer or other person, and I
will not bring onto Company’s premises any unpublished document or any other properly belonging to any former employer without the written consent of that former employer. 

 2. Non-Competition 
  

	 	A.	During my employment with Company, I will perform for Company such duties as it may designate from time to time and will devote my full time and best efforts to the business of
Company and will not, without the prior written approval ( i ) an officer for Company if I am not an executive officer of Company or ( ii ) the board of Managers of Company if I am an executive officer for Company, (a) engage in any
other professional employment or consulting, or (b) directly or indirectly participate in or assist any business which is a current or potential supplier, customer, or competitor of Company. 

  

 8 

			
	Simcere Pharmaceutical Group	  	Employment Agreement

  

	 	B.	I agree that during the term of my employment with Company (whether or not during business hours), I will not engage in any activity that is in any way competitive with the business
or demonstrably anticipated business of Company, and I will not assist any other person or organization in competing or in preparing to compete with any business or demonstrably anticipated business of Company. 

  

	 	C.	During the terms of my employment by Company and for one year thereafter, I shall not directly or indirectly, without the prior written consent of Company, solicit, recruit,
encourage or induce any employees, officers, consultants, contractors or subcontractors of Company to leave the employ of Company, either on my own behalf or on behalf of any other person or entity. 

 3. Proprietary Information 
  

	 	A.	Upon termination of my employment, I will promptly return to Company all items containing or embodying Confidential Information (including all copies), except that I may keep my
personal copies of ( i ) my compensation records, ( ii )materials distributed to shareholders generally and ( iii ) this Agreement. All papers, records, data, notes, drawings, files, documents, samples, devices, products, equipment and
other materials, including copies and in whatever form relating to the business of Company that I possess or create as a result of my Company employment, whether or not confidential, are the sole and exclusive property of Company. In the event of
the termination or expiration of my employment, I will promptly deliver all such materials to Company. 

  

	 	B.	All inventions, ideas, designs, circuits, schematics, formulas, algorithms, trade secrets, works of authorship, developments, processes, techniques, improvements, and related
know-how which result from work performed by me , alone or with others, on behalf of Company or through access to Company confidential Information or property, whether or not patentable or copyrightable (collectively “Inventions”)
shall be the property of Company, and to the extent permitted by law, shall be “works made for hire”. I hereby assign and agree to assign to Company or its designee, without further consideration, my entire right, title and interest in and
to all Inventions, including all rights to obtain, register, perfect and enforce patents, copyrights and other intellectual property protection for inventions. I will disclose promptly and in writing to the individual designated by Company or to my
immediate supervisor all Inventions which I have made or reduced to practice. During my employment and for four years after, I will assist Company (at its expense) to obtain and enforce patents, copyrights and other forms of intellectual property
protection on Inventions. If I use or disclose my own confidential information or intellectual property when acting within the scope of my employment or otherwise on behalf of Company, Company will have and I hereby grant Company a perpetual,
irrevocable, worldwide royalty-free, non-exclusive, sublicensable right and license to exploit and exercise all such confidential information and intellectual property rights. 

  

	 	C.	 I have no entered into, and I agree I will not enter into, any agreement either written or oral in conflict with this Agreement or my employment with Company. I
will not violate any agreement with or rights of any third party or, 

  

 9 

			
	Simcere Pharmaceutical Group	  	Employment Agreement

  

	 	 
except as expressly authorized by Company in writing hereafter, use or disclose my own or any third party’s confidential information or intellectual
property when acting within the scope of my employment or otherwise on behalf of Company. Further, I have not retained anything containing any confidential information of a prior employer or other third party, whether or not created by me.

 4. Miscellaneous 
  

	 	A.	I agree that this Agreement is not an employment contract and does not purport to set forth all of the terms and conditions of my employment. However, the terms of this Agreement
shall supercede any inconsistent terms and can only be changed by a subsequent written agreement signed by Company’s Chairman of the Board and myself. 

  

	 	B.	I agree that my obligation under paragraphs 1,2 and 3 of this Agreement shall continue in effect after termination of my employment, regardless of the reason or reasons for
termination, and whether such termination is voluntary of involuntary on my part., and that Company is entitled to communicate my obligations under this Agreement to any further employer or potential employer of mine. My obligations under paragraphs
1,2 and 3 also shall be binding upon my heirs, executors, assigns, and administrators and shall inure to the benefit of Company, its subsidiaries, successors and assigns. 

  

	 	C.	I agree that if one or more provisions of this Agreement are held to be illegal or unenforceable under applicable laws of the People’s Republic of China, such illegal or
unenforceable portion(s) shall be limited or excluded from this Agreement to be minimum extent required so that this Agreement shall otherwise remain in full force and effect and enforceable in accordance with its terms. I also understand that any
breach of this Agreement will cause irreparable harm to Company for which damages would not be an adequate remedy, and, therefore, Company will be entitled to injunctive relief with respect thereto in addition to any other remedies.

  

	 	D.	I agree that this Agreement shall be executed in both English and Chinese and both language versions are equally effective. 

  

	 	E.	I HAVE READ THIS AGREEMENT CAREFULLY AND I UNDERSTAND AND ACCEPT THE OBLIGATIONS WHICH IT IMPOSES UPON ME WITHOUT RESERVATION, NO PROMISES OR REPRESENTATIONS HAVE BEEN MADE TO ME
TO INDUCE ME TO SIGN THIS AGREEMENT, I SIGN THIS AGREEMENT VOLUNTARILY AND FREELY, IN DUPLICATE, WITH THE UNDERSTANDING THAT ONE COUNTERPART WILL BE RETAINED BY COMPANY AND THE OTHER COUNTERPART WILL BE RETAINED BY ME. 

 

 10 

			
	Simcere Pharmaceutical Group	  	Employment Agreement

  

 Signature 
  

							
		 	Name of Employee:	 	  
	 	
		 		 	 (Signature)
	 	
				
		 	Date:	 	  
	 	
				
		 	ID Card No.:	 	  
	 	
				
		 	Home Address:	 	  
	 	

 Accepted and Agreed by: Simcere Pharmaceutical Group 
  

							
		 	By :	 	  
	 	
		 		 	(Authorized Signature of the Legal Representative)	 	
				
		 	Date:	 	  
	 	

  

 11Form of Non-Disclosure, Non-Competition and Proprietary Information Agreement

 Exhibit 10.3 
 SIMCERE PHARMACEUTICAL GROUP 
 CONFIDENTIAL INFORMATION AND 
 INVENTION ASSIGNMENT AGREEMENT 
 As a
condition of my employment with Simcere Pharmaceutical Group, its subsidiaries, successors or assigns (together the “Company”), and in consideration of my employment with the Company and my receipt of the compensation now and hereafter
paid to me by Company, I agree to the following: 
 1. Confidential Information. 
 a. Company Information. I agree at all times during the term of my employment and thereafter, to hold in strictest confidence, and
not to use, except for the benefit of the Company, or to disclose to any person, firm or corporation without written authorization of the board of directors of the Company, any Confidential Information of the Company. I understand that
“Confidential Information” means any Company proprietary information, technical data, trade secrets or know-how, including, but not limited to, research, product plans, products, services, customer lists and customers (including, but not
limited to, customers of the Company on whom I called or with whom I became acquainted during the term of my employment), markets, software, developments, inventions, processes, formulas, methods, devices, techniques, instruments, materials,
technologies, designs, drawings, engineering, hardware configuration information, all other current or pending intellectual properties, marketing, finances or other business information disclosed to me by the Company either directly or indirectly in
writing, orally or by drawings or observation of parts or equipment. I further understand that Confidential Information does not include any of the foregoing items which has become publicly known and made generally available through no wrongful act
of mine or of others who were under confidentiality obligations as to the item or items involved. 
 b. Former Employer
Information. I agree that I will not, during my employment with the Company, improperly use or disclose any proprietary information or trade secrets of any former or concurrent employer or other person or entity and that I will not bring
onto the premises of the Company any unpublished document or proprietary information belonging to any such employer, person or entity unless consented to in writing by such employer, person or entity. 
 c. Third Party Information. I recognize that the Company has received and in the future will receive from third parties, including
affiliated companies and subsidiaries of the Company, their confidential or proprietary information subject to a duty on the Company’s part to maintain the confidentiality of such information and to use it only for certain limited purposes. I
agree to hold all such confidential or proprietary information in the strictest confidence and not to disclose it to any person, firm or corporation or to use it except as necessary in carrying out my work for the Company consistent with the
Company’s agreement with such third party. 

 2. Inventions. 
 a. Inventions Retained and Licensed. I have attached hereto, as Exhibit A, a list describing all processes, inventions,
technology, original works of authorship, developments, improvements, formulas, patents, discoveries, copyrights and trade secrets which were made by me prior to my employment with the Company (collectively referred to as “Prior
Inventions”), which belong to me, which relate to the Company’s proposed business, products or research and development, and which are not assigned to the Company hereunder; or, if no such list is attached, I represent that there are no
such Prior Inventions. If in the course of my employment with the Company, I incorporate into a Company product, process or machine a Prior Invention owned by me or in which I have an interest, the Company is hereby granted and shall have a
nonexclusive, royalty-free, irrevocable, perpetual, worldwide license to make, have made, modify, use, sell and engage in other actions with respect to such Prior Invention as part of or in connection with such product, process or machine.

 b. Assignment of Inventions. I agree that I will promptly make full written disclosure to the Company, will hold in trust
for the sole right and benefit of the Company, and hereby assign to the Company, or its designee, without further compensation, all my right, title, and interest in and to any and all inventions, original works of authorship, developments, concepts,
improvements or trade secrets, whether or not patentable or registrable under copyright or similar laws, which I may solely or jointly conceive or develop or reduce to practice, or cause to be conceived or developed or reduced to practice, during
the period of time I am in the employment of the Company (collectively referred to as “Inventions”), except as provided in Section 3(c) below. I further agree that all patentable and copyrightable works which are made by me (solely or
jointly with others) within the scope of and during the period of my employment with the Company, are “works made for hire” and I hereby assigns all proprietary rights, including patent and copyright, in these works to the Company without
further compensation. 
 c. Unrelated Inventions. Inventions as referenced to in Section 3(b) does not include inventions
which I can demonstrate to be developed entirely on my own time without using the Company’s equipment, supplies, facilities or trade secret information (the “Unrelated Inventions”), unless those inventions that are either
(i) related at the time of conception or reduction to practice of the invention to the Company’s business, or actual or demonstrably anticipated research or development of the Company, or (ii) result from any work performed by me for
the Company. I agree to disclose promptly to the Company all such Unrelated Inventions and to provide the Company or its assignee first rights of refusal to license such disclosed Unrelated Inventions within three months after my disclosure of such
Unrelated Inventions based on commercially negotiated terms. 
 d. Maintenance of Records. I agree to keep and maintain
adequate and current written records of all Inventions made by me (solely or jointly with others) during the term of my employment with the Company. The records will be in the form of notes, sketches, drawings, and any other format that may be
specified by the Company. The records will be available to and remain the sole property of the Company at all times. 
 e. Patent and
Copyright Registrations. I agree to assist the Company, or its designee, at the Company’s expense, in every proper way to secure the Company’s rights in the Inventions and any copyrights, patents or other intellectual property
rights relating thereto in any 

  

 -2- 

 
and all countries, including the disclosure to the Company of all pertinent information and data with respect thereto, the execution of all applications,
specifications, oaths, assignments and all other instruments which the Company shall deem necessary in order to apply for and obtain such rights and in order to assign and convey to the Company, its successors, assigns, and nominees the sole and
exclusive rights, title and interest in and to such Inventions, and any copyrights, patents or other intellectual property rights relating thereto. I further agree that my obligation to execute or cause to be executed, when it is in my power to do
so, any such instrument or papers shall continue after the termination of this Agreement. If the Company is unable because of my mental or physical incapacity or for any other reason to secure my signature to apply for or to pursue any application
for any domestic or foreign patents or copyright registrations covering Inventions assigned to the Company as above, then I hereby irrevocably designate and appoint the Company and its duly authorized officers and agents as my agent and attorney in
fact, to act for and in my behalf and stead to execute and file any such applications and to do all other lawfully permitted acts to further the prosecution and issuance of letters patent or copyright registrations thereon with the same legal force
and effect as if executed by me. 
 3. Conflicting Employment. I agree that, during the term of my employment with the Company,
I will not engage in any other employment, occupation, consulting or other business activity directly related to the business in which the Company is now involved or becomes involved during the term of my employment, nor will I engage in any other
activities that conflict with my obligations to the Company. 
 4. Non-Competition. I agree that for a period of twelve
(12) months after the termination of my employment with the Company, I shall not, on my own behalf, or as owner, manager, stockholder, consultant, director, officer or employee of or in any other manner connected with any business entity,
participate or be involved in any business of the type and character of business in which the Company engages or proposes to engage in without the prior written authorization of the Company. 
 5. Solicitation of Employees. I agree that for a period of twelve (12) months immediately following the termination of my relationship
with the Company for any reason, whether with or without cause, I shall not either directly or indirectly solicit, induce, recruit or encourage any of the Company’s employees, consultants, contractors or subcontractors to leave their
employment, or take away such employees, consultants, contractors or subcontractors, or attempt to solicit, induce, recruit, encourage or take away employees, consultants, contractors or subcontractors of the Company, either for myself or for any
other person or entity. 
 6. Solicitation of Customers. I agree that for a period of twelve (12) months immediately
following the termination of my relationship with the Company for any reason, whether with or without cause, I shall not either directly or indirectly solicit business or relationship in competition with the Company from any of the Company’s
customers, suppliers or partners or any other entities with which the Company does business, or encourage any such customers, suppliers or partners or any other entities to terminate its relationship with the Company. 
 7. Returning Company Documents. I agree that, at the time of leaving the employment of the Company, I will deliver to the Company (and will
not keep in my possession, 

  

 -3- 

 
recreate or deliver to anyone else) any and all devices, records, data, notes, reports, proposals, lists, correspondence, specifications, drawings
blueprints, sketches, materials, equipment, other documents or property, or reproductions of any aforementioned items developed by me pursuant to my employment with the Company or otherwise belonging to the Company, its successors or assigns,
whether or not such items are considered Confidential Information. In the event of the termination of my employment, I agree to sign and deliver the “Termination Certification” attached hereto as Exhibit B. I acknowledge that
in the event I failed to sign and deliver the Termination Certification upon the termination of my employment, the Company will consider the Termination Certification as signed and delivered to the Company. 
 8. Notification of New Employer. In the event that I leave the employment of the Company, I hereby grant consent to notification by the
Company to my new employer about my rights and obligations under this Agreement. 
 9. Conflict of Interest Guidelines. I agree
to diligently adhere to the Conflict of Interest Guidelines attached as Exhibit C hereto. 
 10. Foreign Corrupt Practices
Act. I agree to diligently adhere to the Foreign Corrupt Practices Act attached hereto as Exhibit D hereto. 
 11.
Representations. I agree to execute any proper oath or verify any proper document required to carry out the terms of this Agreement. I represent that my performance of all the terms of this Agreement will not breach any agreement to
keep in confidence proprietary information acquired by me in confidence or in trust prior to my employment by the Company. I have not entered into, and I agree I will not enter into, any oral or written agreement in conflict herewith. 
 12. General Provisions. 
 a.
Governing Law. This validity, interpretation, construction and performance of this Agreement will be governed by the laws of the People’s Republic of China. 
 b. Entire Agreement. This Agreement sets forth the entire agreement and understanding between the Company and me relating to the subject
matter herein and merges all prior discussions between us. No modification of or amendment to this Agreement, nor any waiver of any rights under this agreement, will be effective unless in writing signed by the party to be charged. Any subsequent
change or changes in my duties, salary or compensation will not affect the validity or scope of this Agreement. 
 c.
Severability. If one or more of the provisions in this Agreement are deemed void by law, then the remaining provisions will continue in full force and effect. 
 d. Successors and Assigns. This Agreement will be binding upon my heirs, executors, administrators and other legal representatives and will
be for the benefit of the Company, its successors, and its assigns. 
 e. Waiver. No failure or delay by the Company in
exercising any right, power, privilege and remedy hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof of the exercise of any other right, power, privilege or
remedies. 
  

 -4- 

 f. Other Rights. All right, power, privilege and remedy granted to the Company under
this Agreement does not exclude the Company from other right, power, privilege and remedy that are available to the Company under the governing law. 
  

							
	 Date:
	 	  
	 		 	
				
		 		 		 	  

		 		 		 	Signature
				
		 		 		 	  

		 		 		 	Name of Employee (typed or printed)
			
	  
	 		 	
	 Witness
	 		 	

  

 -5- 

 Exhibit 10.3 
 EXHIBIT A 
 List of Prior Inventions 
 and Original Works of Authorship 
  

					
	 Title
	  	 Date
	 	 Identifying Number or Brief Description

		  		 	

          No inventions or improvements 
          Additional Sheets Attached 
 Signature of Employee: 
 Print Name of Employee: 
 Date: 

 Exhibit 10.3 
 EXHIBIT B 
 SIMCERE PHARMACEUTICAL GROUP 
 Termination Certification 
 This is to
certify that I do not have in my possession, nor have I failed to return, any devices, records, data, notes, reports, proposals, lists, correspondence, specifications, drawings, blueprints, sketches, materials, equipment, other documents or
property, or reproductions of any aforementioned items belonging to Simcere Pharmaceutical Group, its subsidiaries, successors or assigns (together, the “Company”). 
 I further certify that I have complied with all the terms of the Company’s Confidential Information and Invention Assignment Agreement signed by me,
including the reporting of any inventions and original works of authorship, conceived or made by me (solely or jointly with others) covered by that agreement. 
 I further agree that, in compliance with the Confidential Information and Invention Assignment Agreement, I will preserve as confidential all trade secrets, confidential knowledge, data or other proprietary
information relating to products, processes, know-how, designs, formulas, methods, devices, techniques, developmental or experimental work, instruments, materials, computer programs, data bases, other original works of authorship, all other current
or pending intellectual properties, customer lists, business plans, financial information or other subject matter pertaining to any business of the Company or any of its employees, clients, consultants or licensees. 
 I further agree that for twelve (12) months from this date, I will not and will not attempt to hire any employees, consultants, contractors or
subcontractors of the Company and I will not and will not attempt to solicit, induce, recruit or encourage any of the Company’s employees, consultants, contractors or subcontractors to leave their employment. 
 I further agree that for twelve (12) months from this date, I will not solicit business or relationship in competition with the Company or encourage
the termination of relationship with the Company from any of the Company’s customers, suppliers or partners or any other entities with which the Company does business. 
  

			
	 Date:
                            
	 	
		
		 	  

		 	(Employee’s Signature)
		
		 	  

		 	(Type/Print Employee’s Name)

 EXHIBIT C 
 SIMCERE PHARMACEUTICAL GROUP 
 Conflict of Interest Guidelines 
 It is the policy of Simcere Pharmaceutical Group, its subsidiaries, successors or assigns (together the “Company”) to conduct its affairs in
strict compliance with the letter and spirit of the law and to adhere to the highest principles of business ethics. Accordingly, all officers, employees and independent contractors must avoid activities which are in conflict, or give the appearance
of being in conflict, with these principles and with the interests of the Company. The following are potentially compromising situations which must be avoided. Any exceptions must be reported to the board of directors of the Company and written
approval for continuation must be obtained. 
 1. Revealing confidential information to outsiders or misusing confidential information.
Unauthorized divulging of information is a violation of this policy whether or not for personal gain and whether or not harm to the Company is intended. (The Confidential Information and Invention Assignment Agreement elaborates on this principle
and is a binding agreement.) 
 2. Accepting or offering substantial gifts, excessive entertainment, favors or payments which may be deemed
to constitute undue influence or otherwise be improper or embarrassing to the Company. 
 3. Participating in civic or professional
organizations that might involve divulging confidential information of the Company. 
 4. Initiating or approving personnel actions affecting
reward or punishment of employees or applicants where there is a family relationship or is or appears to be a personal or social involvement. 
 5. Initiating or approving any form of personal or social harassment of employees. 
 6. Investing or holding outside directorship
in suppliers, customers, or competing companies, including financial speculations, where such investment or directorship might influence in any manner a decision or course of action of the Company. 
 7. Borrowing from or lending to employees, customers or suppliers. 
 8. Acquiring real estate of interest to the Company. 
 9. Improperly using or disclosing to the Company any
proprietary information or trade secrets of any former or concurrent employer or other person or entity with whom obligations of confidentiality exist. 
 10. Unlawfully discussing prices, costs, customers, sales or markets with competing companies or their employees. 
  

 -1- 

 11. Making any unlawful agreement with distributors with respect to prices. 
 12. Improperly using or authorizing the use of any inventions which are the subject of patent claims of any other person or entity. 
 13. Engaging in any conduct which is not in the best interest of the Company. 
 Each officer, employee and independent contractor must take every necessary action to ensure compliance with these guidelines and to bring problem areas
to the attention of higher management for review. Violations of this conflict of interest policy may result in discharge without warning. 
  

 -2- 

 EXHIBIT D 
 SIMCERE PHARMACEUTICAL GROUP 
 The Foreign Corrupt Practices Act of 1977 
 The Foreign Corrupt Practices Act of 1977 (the “Act”) amended the federal securities laws to expand the authority of the federal government to
deal with improper business practices and, perhaps more significantly, to create new powers to determine just what constitutes such improper practices. 
 The Act 
 The Act, to which Simcere Pharmaceutical Group, its subsidiaries, successors or assigns (together the
“Company”) will be subject to once it becomes a publicly owned corporation in the United States, was enacted to deter illegal corporate payments by: (1) prohibiting certain payments or promises to foreign officials (anti-bribery
provisions), (2) requiring corporations to keep adequate records of the disposition of their assets, and (3) making corporations responsible for internal monitoring of their accounting practices. In summary, the provisions of the Act in
each of these areas are as follows: 
 Anti-Bribery Provisions 
 This portion of the Act makes it a criminal offense for an employee (or an officer, director, agent or shareholder of the corporation) to make an offer,
payment or gift of any money or other item of value, directly or indirectly, to (i) a foreign official, (ii) a foreign political party, (iii) a party official or (iv) a candidate for foreign political office for the
“corrupt” purpose of obtaining or retaining business for the Company or for the purpose of directing business to any other person. The term “corrupt” is construed to prohibit any activity, including the provision of meals,
lodging or entertainment, which is meant to influence the recipient and which is done for the stated illegal purposes. This highly publicized provision carries with it prosecution of officers, directors, employees or agents resulting in fines of up
to US$100,000 or imprisonment of up to five years, or both. 
 The Act does provide a narrow exception for payments to a foreign official,
foreign political party, or party official intended to hasten or secure the performance of a “routine governmental action.” Such “routine governmental actions” are those ordinarily performed by a foreign official in: 

 

	 	(1)	obtaining permits, licenses, or other official documents to qualify a person to do business in a foreign country; 

  

	 	(2)	processing governmental papers, such as visas and work orders; 

  

	 	(3)	providing police protection, mail pick-up and delivery, or scheduling inspections associated with contract performance or inspections related to transit of goods across country;

  

 -1- 

	 	(4)	providing phone service, power and water supply, loading and unloading cargo, or protecting perishable products or commodities from deterioration; or 

  

	 	(5)	actions of a similar nature. 

 In addition, the Act
provides two affirmative defenses to charges of violations. First, it is a defense to a charge if the payment or promise was lawful under the written laws and regulations of the country in which the recipient is located. Second, “reasonable and
bona fide expenditures” made to foreign officials do not violate the Act. For example, the Company may reimburse foreign officials for the cost of travel and lodging in connection with (i) the promotion, demonstration, or explanation of
products or services, or (ii) the execution or performance of a contract with a foreign government. 
 The Exchange Act 
 Record-Keeping Provisions 
 Pursuant to Section 13(b)(2)(A) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company is required to make and keep books, records and accounts which, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the Company. The purpose of this requirement is to prevent the occurrence of the following types of abuses: 
  

	 	(1)	Records that accurately record the existence of a transaction but which fail to reveal the illegal or improper purpose of the transaction. 

  

	 	(2)	Records that fail to record improper transactions. 

  

	 	(3)	Records that are falsified to conceal improper transactions which are otherwise correctly recorded. 

 Internal Accounting Control Provisions 
 Pursuant to Exchange Act Section 13(b)(2)(B), the Company must devise and maintain a system of internal accounting controls sufficient to provide reasonable assurances that the following objectives are achieved: 
  

	 	(1)	Transactions are executed in accordance with management’s general and specific authorization. 

  

	 	(2)	Transactions are recorded in a way which will permit the preparation of proper financial statements and will maintain accountability for assets. 

  

	 	(3)	Access to assets is permitted only in accordance with management’s general and specific authorizations. 

  

 -2- 

	 	(4)	Audits are conducted at reasonable intervals and appropriate action is taken with respect to any deficiencies in accountability for assets. 

 Simcere Pharmaceutical Group 
 It is the policy
of Simcere Pharmaceutical Group, its subsidiaries, successors or assigns (together the “Company”) that: 
  

	 	(1)	The use of Company funds or assets for any unlawful or improper purpose is strictly prohibited. No payment shall be made to, or for the benefit of, government employees for the
purpose of, or otherwise in connection with, the securing of sales to or obtaining favorable action by a government agency. Gifts of substantial value to or lavish entertainment of government employees are prohibited since they can be construed as
attempts to influence government decisions in matters affecting the Company’s operation. Any entertaining of public officials, or the furnishing of assistance in the form of transportation or other services should be of such nature that the
official’s integrity or reputation will not be compromised. 

  

	 	(2)	The offer, payment or promise to transfer in the future company funds or assets or the delivery of gifts or anything else of value to foreign officials, foreign political parties or
officials or candidates of foreign political parties is strictly prohibited for the purpose of influencing any act or decision of any such person in his or her official capacity, including the decision to fail to perform his or her official
functions or to use such persons or party’s influence with a foreign government or instrumentality in order to affect or to influence any act or decision of such government or instrumentality in order to assist the Company in obtaining or
retaining business for or with, or directing business to any person or entity. 

  

	 	(3)	All records must truly reflect the transactions they record. All assets and liabilities shall be recorded in the regular books of account. No undisclosed or unrecorded fund or asset
shall be established for any purpose. No false or artificial entries shall be made in the books and records for any reason. No payment shall be approved or made with the intention or understanding that any part of such payment is to be used for any
purpose other than that described by the document supporting the payment. 

  

	 	(4)	No political contribution shall be made, directly or indirectly, with corporate funds or assets regardless of whether the contributions are legal under the laws of the county in
which they are made. 

  

	 	(5)	Any employee who learns of or suspects a violation of this policy should promptly report the matter to the President, Chief Financial Officer or Internal Auditor, as appropriate in
the circumstances. All managers shall be responsible for the enforcement of and compliance with this policy, including the necessary distribution to insure employee knowledge and compliance. 

  

 -3-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}]]